Pulmonary Arterial Hypertension: Rapid Sequential Combination Therapy With PDE5 Inhibitors and Endothelin Receptor Antagonists Substantially Improves Hemodynamics at Early Follow-Up

Introduction: Evidence suggests that upfront combination therapy with ERA and PDE5i in patients with newly diagnosed PAH is associated with a reduction in morbidity and mortality events. No data ar...